RECRUITINGOBSERVATIONAL
Evaluation of HEArt invoLvement in Patients With FABRY Disease
Prospective Monocentric Cohort Study to Evaluate Predictors for Heart Failure and Sudden Cardiac Death in Patients With Fabry Disease
About This Trial
This study evaluates predictors for the incidence of arrhythmias and sudden cardiac death as well as terminal heart failure in patients with Fabry disease.
Who May Be Eligible (Plain English)
Who May Qualify:
- Fabry disease (genetically confirmed)
- Signed willing to sign a consent form
- 18 years and older
Who Should NOT Join This Trial:
- No willing to sign a consent form
- Withdrawal of willing to sign a consent form
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Fabry disease (genetically confirmed)
* Signed informed consent
* 18 years and older
Exclusion Criteria:
* No informed consent
* Withdrawal of informed consent
Locations (1)
Wuerzburg University Hospital
Würzburg, Bavaria, Germany